//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...









Loading...
#AntimicrobialResistance Patient Advocate • Chair @WHO Taskforce of AMR Survivors • @AfricaCDC Civil Society Champion • Founder of @theAMRnarrative
Vanessa Carter
Patient partners aren't study subjects. Patient partner research has a compensation crisis. We must do better to promote equity and ensure that patient partnerships are respected and compensated. Important article below: www.bmj.com/content/388/bmj.r381 #PPIE #PatientsIncluded #AMR
Have you heard about the new #TrinityChallenge on #AMR? This time looking for innovative solutions to improve stock control and reduce substandard and falsified oral antibiotics. Apply by 24 April 2025 for a chance to win up to £1 million: solve.mit.edu/challenges/t... #AntibioticEmergency
CARB-X thanks Letícia de Oliveira Batista and Pernilla Rönnholm for sharing their sepsis survivor stories at the CARB-X PD Conference in 2024. Sharing patient stories is key to understanding #AMR and its impact on lives. 🔗 Learn more: SepsisSurvivorWeek.org
Patient partners play a vital role in research but face systemic barriers to fair pay. Institutions must match their equity commitments with action—transparent, equitable compensation is long overdue.
Thanks so much for joining us, Vanessa.
Microbiotalk 1st edition on #AMR is online with talks by Vanessa Carter PhD. Elitsa Penkova Prof. Etienne Ruppé Prof. Søren J. Sørensen Edith Odeh Pharma D. Greatman A Owhor In this conference series, experts share insights on #microbiota and this major health challenge Watch👇 bit.ly/3QxLrU4
@bluesky is growing, but I'm worried we lose significant voices on other platforms like X when it comes to reaching patients and the public on matters around #AMR. X=700M users I know SM is a tough battleground, but having a diverse presence is important to patients who are seeking information
Antimicrobial Resistance (AMR) is a global health security threat. 🗓️ The fourth dialogue in our AMR series will convene key stakeholders with a focus on actionable steps addressing the health, social, and economic impacts of AMR. 🔗 www.wiltonpark.org.uk/event/reinvi... #AMR #health
Such a pleasure to join the Biocodex Foundation to share my story about surviving #AMR in November last year. Very interesting presentations around the microbiota and antibiotic resistance from fellow speakers #theAMRnarrative
I've said it a few times this week. The new #UNGA political declaration mentions participatory approaches, including patients In the UK, we have the NIHR Involvement Guidance. This should be relevant in all countries Check out their resources: x.com/NIHRinvolvem... #PPIE #PatientsIncluded #AMR
Mar 2, 2025
Feb 25, 2025
Mar 3, 2025
Feb 10, 2025
Feb 17, 2025
Feb 25, 2025
Feb 26, 2025
Feb 12, 2025
Feb 26, 2025
Feb 27, 2025
Vanessa Carter
The British Society for Antimicrobial Chemotherapy
CARB-X
Antimicrobial resistance #AMR
Vanessa Carter
Wilton Park
Wilton Park
Vanessa Carter
Vanessa Carter
Biocodex Microbiota Institute
The Trinity Challenge: Community Access to Effective Antibiotics | MIT Solve
solve.mit.edu